Section 22-B6806. MEDICAL DIAGNOSTIC USES

 

6806.1A general license shall be issued to any physician to receive, possess, transfer, or use for any of the following diagnostic uses, in accordance with the provisions of §§6806.2 through 6806.6 of this section, the following radioactive materials in capsules, disposable syringes, or other forms of prepackaged individual doses:

 

(a)Iodine 131 as sodium iodide (NaI131) for measurement of thyroid uptake;

 

(b)Iodine 131 as iodinated human serum albumin (IHSA) for determinations of blood plasma volume;

 

(c)Iodine 125 as iodinated human serum albumin (IHSA) for determinations of blood and blood plasma volume;

 

(d)Cobalt 57, Cobalt 58, and Cobalt 60 for the measurement of intestinal absorption of cyanocobalamin; and

 

(e)Chromium 51 as sodium radiochromate for determinations of red blood cell volumes and studies of red blood cell survival time.

 

6806.2No physician shall receive, possess, use, or transfer radioactive material pursuant to the general license established in §6806.1, except in accordance with the terms of a certificate issued by the Director.

 

6806.3Application for the certification required in §6806.2 shall be filed on a form prescribed by the Director, and shall contain information as may be required by the Director.

 

6806.4The physician shall report in writing any changes in the information furnished in the form within thirty (30) days of the change.

 

6806.5A physician who receives, possesses, or uses a pharmaceutical containing radioactive material pursuant to the general license established in §6806.1 shall do the following:

 

(a)Store the pharmaceutical until administered in the original shipping container, or a container providing equivalent radiation protection; and

 

(b)Use the pharmaceutical only for the uses authorized by §6806.1.

 

6806.6A physician who receives, possesses, or uses a pharmaceutical containing radioactive material pursuant to the general license established in §6806.1 shall not do the following

 

(a)Possess at any one (1) time, pursuant to the general license in §6806.1, more than the following substances:

 

(1)Two hundred (200) microcuries of iodine 131;

 

(2)Two hundred (200) microcuries of iodine 125;

 

(3)Five (5) microcuries of cobalt 57;

 

(4)Five (5) microcuries of cobalt 58;

 

(5)Five (5) microcuries of cobalt 60; or

 

(6)Two hundred (200) microcuries of chromium 51.

 

(b)Administer the pharmaceutical to a woman with a confirmed pregnancy or to a person under eighteen (18) years of age;

 

(c)Transfer the radioactive material to a person who is not authorized to receive it pursuant to a license issued by the Director, the AEC, or any agreement state; and

 

(d)Transfer the radioactive material in any manner other than in the unopened, labeled shipping container as received from the supplier, except by administering it to a patient.

 

source

Regulation No. 70-33 (July 10, 1970), 17 DCR 39 (July 27, 1970); 6A DCRR §8-2:1018(g); as amended by Final Rulemaking published at 53 DCR 3721 (May 5, 2006).